A Study to Evaluate A Resilient Living Program for Patients with Advancer Cancer and Their Caregivers

Overview

About this study

The primary purpose of this study is to determine feasibility as measured by consent of at least 25% of eligible patients and their caregivers (defined as those who met with the study coordinator), adherence (75% of the enrolled participants will complete at least 3 of the 4 Resilient Living sessions), and acceptability (measured by ) of the delivery of the Resilient Living intervention to patients with advanced cancer and their caregivers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Patients:

  • Age  ≥ 18 years old.
  • English fluency.
  • No diagnosed severe cognitive impairment.
  • Diagnosis of advanced, incurable solid tumor cancer.
  • Expected prognosis > 6 months.
  • Provide informed consent (written or electronic).
  • Ability to complete questionnaire(s) by themselves or with assistance.
  • Patient baseline distress score ≥ 4/10 OR identified as having distress that would benefit from program by care team or provider.
  • Ability to do first Resilient Living session in person.

Inclusion Criteria - Caregivers:

  • Self-identifies as a caregiver of a patient that meets the above cancer diagnosis criteria, and who also participates in the study.
  • Provide informed consent (written or electronic).
  • Ability to complete questionnaire(s) by themselves or with assistance.
  • Age ≥ 18 years old.
  • English fluency.
  • No diagnosed severe cognitive impairment.
  • Ability to do first Resilient Living session in person.

Exclusion Criteria: 

  • As determined through self-report, those diagnosed with a history of a psychotic episode will be excluded.
  • Other psychological co-morbidities such as untreated schizophrenia, bipolar disease.
  • Participated in the Mayo Clinic study entitled “Feasibility and Acceptability of a Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals with Advanced Cancer Undergoing Outpatient Chemotherapy."

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Deirdre Pachman, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20480310

Mayo Clinic Footer